| Record ID | ia:impactofmedicaid00univ_1 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/impactofmedicaid00univ_1/impactofmedicaid00univ_1_marc.xml |
| Download MARC binary | https://www.archive.org/download/impactofmedicaid00univ_1/impactofmedicaid00univ_1_meta.mrc |
LEADER: 01459cam 22003017a 4500
001 40620639
008 960305s1995 mdua 000 0 eng
010 $a96121690
035 $a(OCoLC)40620639
040 $aDLC$cDLC$dHEC
049 $aHECA
050 4 $aHG9391.5.U5$bI56 1995
245 00 $aImpact of the Medicaid drug rebate program /$c[prepared by the Institute for Health Services Research at the University of Minnesota].
260 $aBaltimore, Md. :$bU.S. Department of Health and Human Services, Health Care Financing Administration, Office of Research and Demonstrations,$c[1995]
300 $a43 p. :$bill. ;$c28 cm.
490 1 $aExtramural research report.
490 1 $aHCFA pub. ;$vno. 03372.
500 $a"This report was financed by the Health Cre Financing Administration under Contract [no.] 500-92-0022"--T.p. verso.
504 $aIncludes bibliographical references.
650 0 $aPharmaceutical services insurance$zUnited States.
650 0 $aDrugs$xPrices$xLaw and legislation$zUnited States.
650 0 $aPrescription pricing$zUnited States.
650 0 $aPharmaceutical industry$xGovernment policy$zUnited States.
650 0 $aMedicaid.
710 2 $aUniversity of Minnesota.$bInstitute for Health Services Research.
710 1 $aUnited States.$bHealth Care Financing Administration.$bOffice of Research and Demonstrations.
830 0 $aHCFA pub. ;$vno. 03372.
830 0 $aHealth care financing.$pExtramural research report.